arrow
A

Alexandre Gaspar-Maia

Mayo Clinic
H指数:18
被引数:2,957

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mitochondrial metabolism and epigenetic crosstalk drive SASP

线粒体代谢与表观遗传学串扰驱动SASP

Nature
IF48.5
2026-07-290
OA
Single-cell resolution of an open chromatin signature in persister tumor cells

持久性肿瘤细胞中开放染色质特征的单细胞分辨率

2026-01-030
OAAI
DISSECTING MYC-DRIVEN EPIGENETIC MECHANISMS THAT PROMOTE GROUP 3 MEDULLOBLASTOMA UTILIZING HUMANIZED IPSC MODELS

利用人源化iPSC模型解析促进3组髓母细胞瘤的MYC驱动的表观遗传机制

2025-11-010
OAAI
DNMT3A Mutant Clonal Hematopoiesis in Vexas Syndrome Epigenetically Potentiates IL-13 and IL-15 Inflammatory Pathways and Is Associated with Increased Mortality

DNMT3A突变克隆性造血在Vexas综合征中表观遗传学上增强了IL-13和IL-15炎症通路,并与死亡率增加相关。

BLOOD
IF23.1
2024-11-050
PRE
Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14)

11 q13.3的功能变体rs9344调节t(11;14) 多发性骨髓瘤中CCND1的表达

LEUKEMIA
IF13.4
2024-10-140
OAAI
IL-4 drives exhaustion of CD8+ CART cells

IL-4驱动CD8 CART细胞耗尽

2024-09-120
OAAI
RNA Shielding of p65 Is Required to Potentiate Oncogenic Inflammation in TET2-Mutated Clonal Hematopoiesis
2024-08-270
PRE
Diversity of post-translational modifications and cell signaling revealed by single cell and single organelle mass spectrometry

单细胞和单细胞质谱揭示的翻译后修饰和细胞信号的多样性

2024-07-192
OAAI
Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML
2023-05-242
OA
Enhancer deregulation in TET2- mutant clonal hematopoiesis is associated with increased COVID-19 severity and mortality
2023-04-041
PRE
MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogramming
2023-02-238
OAAI
Oncogenic deubiquitination controls tyrosine kinase signaling and therapy response in acute lymphoblastic leukemia
2022-12-096
OAAI